Adenosine A2b Receptor Protein (ADORA2B) (Fc Tag)
-
- Antigène Voir toutes Adenosine A2b Receptor (ADORA2B) Protéines
- Adenosine A2b Receptor (ADORA2B)
- Type de proteíne
- Recombinant
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette Adenosine A2b Receptor protéine est marqué à la Fc Tag.
- Séquence
- ADORA2B(Asn145-Pro178)+hFc(Glu99-Ala330)
- Attributs du produit
- Tagged Protein: C-Human Fc tag
- Purification
- affinity purification
- Top Product
- Discover our top product ADORA2B Protéine
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute with deionized water
- Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- Agent conservateur
- Without preservative
- Stock
- -80 °C
- Stockage commentaire
- Store at -80°C for 12 months (Avoid repeated freezing and thawing)
- Date de péremption
- 12 months
-
- Antigène
- Adenosine A2b Receptor (ADORA2B)
- Autre désignation
- ADORA2B (ADORA2B Produits)
- Synonymes
- si:dkey-13b16.1 Protein, ADORA2B Protein, LOC606745 Protein, LOC100220469 Protein, ADORA2 Protein, A2BAR Protein, A2BR Protein, A2b Protein, AA2BR Protein, AI480866 Protein, AI605384 Protein, adenosine A2b receptor Protein, adenosine A2B receptor Protein, adora2b Protein, ADORA2B Protein, Adora2b Protein
- Sujet
-
Synonymes: ADORA2
Description: This gene encodes an adenosine receptor that is a member of the G protein-coupled receptor superfamily. This integral membrane protein stimulates adenylate cyclase activity in the presence of adenosine. This protein also interacts with netrin-1, which is involved in axon elongation. The gene is located near the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008] - Poids moléculaire
- 39.27 kDa
- UniProt
- P29275
- Pathways
- cAMP Metabolic Process, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process
-